Condition: Liver Cirrhosis · Sponsor: University of Aarhus
The purpose is to investigate the effect of faecal microbiota transplantation (FMT) on complications, progression, and mortality of patients with liver cirrhosis. Further, the investigators want to examine the impact of FMT on the gut microbiota, gut barrier function, systemic inflammation, and immune function.
This description comes directly from the study's public registry record.
Karen Louise Thomsen, PhD · +4526949260 · karethom@rm.dk
Sidsel Støy, PhD · +4561664565 · sidsel.stoy@clin.au.dk
Always discuss trial participation with your own doctor first.
| Department of Hepatology and Gastroenterology, Aarhus University Hospital | Aarhus, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04932577